[三季报]珀莱雅(603605):珀莱雅化妆品股份有限公司2022年第三季度报告（英文版）
|
时间：2022年10月27日 16:07:56 中财网 |
|
原标题:珀莱雅:珀莱雅化妆品股份有限公司2022年第三季度报告（英文版）
Stock Code: 603605 Stock Abbreviation : Proya
Bond Code: 113634 Bond Abbreviation: Proya convertible bond
Proya Cosmetics Co., Ltd.
The Third Quarter Report in 2022
The Board of Directors and all directors of the Company warrant that the contents
herein are free from misrepresentations, misleading statements or material omissions, and
they will be jointly and severally liable for the authenticity, accuracy and completeness
thereof.
Important Note:
The Board of Directors, Board of Supervisors, directors, supervisors and officers of the Company warrant that the contents of the Quarterly Report are authentic, accurate and complete without any misrepresentations, misleading statements or material omissions, and they will be jointly and severally
liable therefor.
The Chairman, the chief financial officer and the head of the accounting department warrant that the
financial statements herein is authentic, accurate and complete.
Whether the third quarter financial statements have been audited. ?Yes √No
I. Main Financial Data
(I) Main Accounting Data and Financial Indicators
Unit: Yuan Currency: RMB
| Item | The Reporting
Period | YOY change
in the
Reporting
Period (%) | From the beginning
of the year to the end
of the Reporting
Period | YOY change in the
period from the
beginning of the year
to the end of the
Reporting Period (%) | | Operating income | 1,336,130,787.67 | 22.07 | 3,962,074,031.96 | 31.53 | | Net profit attributable to
shareholders of the listed | 198,375,641.64 | 43.55 | 495,315,157.18 | 35.96 | | company | | | | | | Net profit attributable to
shareholders of the listed
company after deducting
non-recurring profit or loss | 196,100,724.25 | 44.07 | 476,998,142.78 | 33.84 | | Net cash flow from
operating activities | N/A | N/A | 771,873,333.67 | 57.37 | | Basic earnings per share
(RMB/share) | 0.71 | 2.90 | 1.76 | -3.30 | | Diluted earnings per share
(RMB/share) | 0.70 | 1.45 | 1.74 | -3.87 | | Weighted average return on
equity (%) | 6.59 | Up by 1.17
percentage
points | 16.51 | Up by 2.01 percentage
points | | | End of the
Reporting Period | End of prior year | Change at the end of
the Reporting Period
over the end of prior
year (%) | | | Total assets | 5,461,758,028.57 | 4,633,049,783.03 | 17.89 | | | Owner’s equity attributable
to shareholders of the listed
company | 3,178,288,666.18 | 2,876,975,835.98 | 10.47 | |
Note: “The Reporting Period” shall refer to the 3-month period ended September 30, 2022, as follows.
(II) Items and Amounts of Non-recurring Profit or Loss
Unit: Yuan Currency: RMB
| Item | Amount in the Reporting
Period | Amount in the period from
the beginning of the year
to the end of the Reporting
Period | Note | | Gains or losses from
disposal of non-current
assets | | | | | Unauthorized examination
and approval, or lack of
official approval
documents, or occasional
tax revenue return and
abatement | | | | | Government grants
recognized in profit or
loss for the current period
(excluding government
grants that are closely | 3,140,446.53 | 23,580,544.90 | | | related to the Company’s
business operations and
gained at a fixed amount
or quantity according to
national uniform
standards) | | | | | Capital occupation fees
charged to the
non-financial enterprises
and included in profit or
loss for the current period | | | | | Gains when the
investment cost of
acquiring a subsidiary, an
associate and a joint
venture is less than the fair
value of the identifiable
net assets of the investee | | | | | Gains or losses from
exchange of non-monetary
assets | | | | | Gains or losses from
entrusting others with
investment or asset
management | | | | | Asset impairment
provision made resulting
from force majeure such
as natural disasters | | | | | Gains or losses from debt
restructuring | | | | | Enterprise restructuring
fees, such as staffing
expenses and integration
fees | | | | | Gains or losses that
exceeds the fair value in
transaction with unfair
price | | | | | Current net gains or losses
of subsidiaries established
by business combination
involving enterprises
under common control
from the beginning of the
period to the combination
date | | | | | Gains or losses on
contingencies that have no
relation with the normal
operation of the Company | | | | | Gains or losses from
change in fair value by
held-for-trading financial
assets, derivative financial
assets, held-for-trading
financial liabilities and
derivative financial
liabilities, and investment
income from disposal of
held-for-trading financial
assets, derivative financial
assets, held-for-trading
financial liabilities,
derivative financial
liabilities and other debt
investments, excluding the
effective hedging
businesses related with
normal operations of the
Company | | | | | Reversal of impairment
provision of accounts
receivable and contract
assets that have undergone
impairment test alone | | | | | Gains or losses from
outward entrusted loaning | | | | | Gains or losses from
changes in the fair values
of investment properties
that are subsequently
measured using the fair
value model | | | | | Impact of a one-time
adjustment on current
profit and loss according
to the requirements of tax
and accounting laws and
regulations | | | | | Custody fees of entrusted
operation | | | | | Other non-operating
income and expenses
besides the above items | -66,506.02 | 214,968.49 | | | Other items that conform
to the definition of
non-recurring profit or
loss | | | | | Less: Effect of income tax | 806,896.17 | 4,416,105.71 | | | Effect of minority
equity (after tax) | -7,873.05 | 1,062,393.28 | | | Total | 2,274,917.39 | 18,317,014.40 | |
Descriptions on classifying non-recurring profit and loss items defined in the Explanatory Announcement No. 1 for Public Company Information Disclosures - Non-recurring Profit and Loss as recurring profit and loss items.
?Applicable √N/A
(III) Changes in Main Accounting Data and Financial Indicators and Main Reasons √Applicable ?N/A
| Item | Change ratio (%) | Primary reasons | | Operating income (from the
beginning of the year to the
end of the Reporting Period) | 31.53 | Mainly due to: 1. the YOY increase in the online channel
income; 2. the rapid growth of the Second-growth-curve
brands. | | Net profit attributable to
shareholders of the listed
company (the Reporting
Period) | 43.55 | Mainly due to: 1. the YOY increase in the online channel
income; 2. the increase of gross profit margin and the
YOY increase in gross profit, operating profit and total
profit. | | Net profit attributable to
shareholders of the listed
company after deducting
non-recurring profit or loss
(the Reporting Period) | 44.07 | The specific reasons are the same as above. | | Net profit attributable to
shareholders of the listed
company (from the beginning
of the year to the end of the
Reporting Period) | 35.96 | Mainly due to: 1. the YOY increase in the online channel
income; 2. (1) Ningbo Timage Cosmetics Co., Ltd. (a
controlled subsidiary of the Company) turned losses into
profits during the Reporting Period; (2) Shanghai
Healthlong Biochemical Technology Co., Ltd. (a
controlled subsidiary of the Company) has ceased to be
included in the consolidated financial statements since
May 2021. | | Net profit attributable to
shareholders of the listed
company after deducting
non-recurring profit or loss
(from the beginning of the year
to the end of the Reporting
Period) | 33.84 | The specific reasons are the same as above. | | Net cash flow from operating
activities (from the beginning
of the year to the end of the
Reporting Period) | 57.37 | Mainly due to: the YOY increase in the operating income
and the increase of cash inflows from operating activities. |
II. Shareholders Information
(I) Total Number of Common Shareholders, Number of Preferred Shareholders with Voting Rights, and the Shareholding of Top Ten Shareholders
Unit: share
| Total number of common
shareholders by the end of the
Reporting Period | 13,764 | Total number of preferred shareholders
with voting rights by the end of the
Reporting Period (if any) | 0 | | | | | Shareholdings of top ten shareholders | | | | | | | | Name of shareholder | Nature of
shareholder | Number of
shares held | Shareholding
ratio (%) | Number of
restricted
shares | Pledged, placed
with mark,
lock-up or not | | | | | | | | Share
status | Number | | HOU Juncheng | Domestic
natural person | 97,670,741 | 34.45 | 0 | None | | | Hong Kong Securities Clearing
Company Limited | Other | 65,496,052 | 23.10 | 0 | None | | | FANG Yuyou | Domestic
natural person | 49,639,480 | 17.51 | 0 | None | | | China Construction Bank Co.,
Ltd. - Yinhua Fuyu Theme
Hybrid Securities Investment
Fund | Other | 5,900,165 | 2.08 | 0 | None | | | China Construction Bank Co.,
Ltd. - CUAM Consumer
Industry Hybrid Securities
Investment Fund | Other | 2,600,058 | 0.92 | 0 | None | | | Aberdeen Standard Investment
Management (Asia) Co., Ltd. -
Aberdeen Standard - China
A-share Equity Fund | Other | 2,552,293 | 0.90 | 0 | None | | | Industrial and Commercial Bank
of China Limited - Jingshun
Changcheng Emerging Growth
Hybrid Securities Investment
Fund | Other | 2,380,000 | 0.84 | 0 | None | | | CAO Liangguo | Domestic
natural person | 2,268,997 | 0.80 | 0 | None | | | Industrial and Commercial Bank
of China Limited - CUAM
Consumption Upgrade Hybrid
Securities Investment Fund | Other | 1,100,038 | 0.39 | 0 | None | | | XU Junqing | Domestic
natural person | 926,239 | 0.33 | 0 | None | | | Shareholding of top ten unrestricted shareholders | | | | | | | | Name of shareholder | Number of unrestricted
outstanding shares held | Type and number of shares | | | | | | | | Type | Number | | | | | HOU Juncheng | 97,670,741 | RMB common stock | 97,670,741 | | | | | Hong Kong Securities Clearing
Company Limited | 65,496,052 | RMB common stock | 65,496,052 | | | | | FANG Yuyou | 49,639,480 | RMB common stock | 49,639,480 | | | | | China Construction Bank Co., Ltd.
- Yinhua Fuyu Theme Hybrid
Securities Investment Fund | 5,900,165 | RMB common stock | 5,900,165 | | | | | China Construction Bank Co., Ltd.
- CUAM Consumer Industry
Hybrid Securities Investment
Fund | 2,600,058 | RMB common stock | 2,600,058 | | | | | Aberdeen Standard Investment
Management (Asia) Co., Ltd. -
Aberdeen Standard - China
A-share Equity Fund | 2,552,293 | RMB common stock | 2,552,293 | | | | | Industrial and Commercial Bank
of China Limited - Jingshun
Changcheng Emerging Growth
Hybrid Securities Investment
Fund | 2,380,000 | RMB common stock | 2,380,000 | | | | | CAO Liangguo | 2,268,997 | RMB common stock | 2,268,997 | | | | | Industrial and Commercial Bank
of China Limited - CUAM
Consumption Upgrade Hybrid
Securities Investment Fund | 1,100,038 | RMB common stock | 1,100,038 | | | | | XU Junqing | 926,239 | RMB common stock | 926,239 | | | | | Description of the association
relationship or concerted action of
the above shareholders | FANG Yuyou is the younger brother of HOU Juncheng’s spouse FANG
Aiqin, so HOU Juncheng and FANG Yuyou are related. | | | | | | | Description of the participation of
the top 10 shareholders and the
top 10 unrestricted shareholders in
the margin trading and refinancing
business (if any) | None | | | | | |
III. Other Reminders
Other important information about the Company’s business during the Reporting Period for the attentions of investors
?Applicable √N/A
IV. Quarterly Financial Statements
(I) Type of Audit Opinion
?Applicable √N/A
(II) Financial Statements
Consolidated Balance Sheet
September 30, 2022
Prepared by: Proya Cosmetics Co., Ltd.
Unit: Yuan Currency: RMB Audit Type: Unaudited
| Item | September 30, 2022 | December 31, 2021 | | Current assets: | | | | Cash and cash equivalents | 2,894,581,365.15 | 2,391,048,249.81 | | Balances with clearing agencies | | | | Placements with banks and other financial institutions | | | | Held-for-trading financial assets | | | | Derivative financial assets | | | | Notes receivable | | | | Accounts receivable | 61,903,721.27 | 138,626,627.90 | | Receivable financing | 3,031,831.88 | 3,242,000.00 | | Prepayments | 174,958,003.94 | 58,406,647.11 | | Premiums receivable | | | | Amounts receivable under reinsurance contracts | | | | Reinsurer's share of insurance contract reserves | | | | Other receivables | 20,569,960.98 | 66,043,707.81 | | Including: Interest receivable | | | | Dividends receivable | | | | Financial assets purchased under resale agreements | | | | Inventories | 690,124,090.74 | 447,938,758.29 | | Contract assets | | | | Held-for-sale assets | | | | Non-current assets due within one year | | | | Other current assets | 36,682,817.91 | 53,534,962.39 | | Total current assets | 3,881,851,791.87 | 3,158,840,953.31 | | Non-current assets: | | | | Loans and advances to customers | | | | Debt investments | | | | Other debt investments | | | | Long-term receivables | | | | Long-term equity investments | 151,406,031.44 | 169,959,536.27 | | Other investments in equity instruments | 146,402,400.00 | 56,402,400.00 | | Other non-current financial assets | | | | Investment properties | 69,349,497.02 | 70,321,868.00 | | Fixed assets | 553,359,059.64 | 558,981,209.20 | | Construction in progress | 177,430,957.16 | 108,678,896.27 | | Bearer biological assets | | | | Oil and gas assets | | | | Right of use assets | | | | Intangible assets | 424,758,523.08 | 397,145,124.29 | | Development expenditure | | | | Goodwill | | | | Long-term prepaid expenses | 22,255,673.60 | 29,756,474.11 | | Deferred income tax assets | 30,463,707.85 | 38,796,018.02 | | Other non-current Assets | 4,480,386.91 | 44,167,303.56 | | Total non-current assets | 1,579,906,236.70 | 1,474,208,829.72 | | Total assets | 5,461,758,028.57 | 4,633,049,783.03 | | Current liabilities: | | | | Short-term borrowings | 200,251,506.85 | 200,251,506.85 | | Loans from the central bank | | | | Taking from banks and other financial institutions | | | | Held-for-trading financial liabilities | | | | Derivative financial liabilities | | | | Notes payable | 64,606,867.00 | 79,156,771.40 | | Accounts payable | 678,833,258.07 | 404,026,241.16 | | Receipts in advance | 527,929.95 | 173,769.85 | | Contract liabilities | 115,157,348.57 | 91,151,985.32 | | Financial assets sold under repurchase agreements | | | | Customer deposits and deposits from banks and other
financial institutions | | | | Funds from securities trading agencies | | | | Funds from underwriting securities agencies | | | | Employee benefits payable | 117,186,385.92 | 78,649,049.72 | | Taxes payable | 109,722,579.78 | 99,893,176.97 | | Other payables | 227,670,691.33 | 62,162,153.55 | | Including: Interest payable | | | | Dividends payable | | | | Fees and commissions payable | | | | Amounts payable under reinsurance contracts | | | | Held-for-sale liabilities | | | | Non-current liabilities due within one year | | | | Other current liabilities | 11,562,619.94 | 9,521,415.32 | | Total current liabilities | 1,525,519,187.41 | 1,024,986,070.14 | | Non-current liabilities: | | | | Insurance contract reserves | | | | Long-term borrowings | | | | Bonds payable | 718,644,660.27 | 695,586,778.80 | | Including: Preferred stock | | | | Perpetual bonds | | | | Lease liabilities | | | | Long-term payables | | | | Long-term employee benefits payable | | | | Provisions | 8,456,756.79 | 10,812,084.88 | | Deferred income | 4,856,945.83 | 6,416,263.33 | | Deferred income tax liabilities | 7,523,121.46 | 8,408,158.81 | | Other non-current liabilities | | | | Total non-current liabilities | 739,481,484.35 | 721,223,285.82 | | Total liabilities | 2,265,000,671.76 | 1,746,209,355.96 | | Owner’s equity (or shareholders’ equity ): | | | | Paid-in capital (or share capital) | 283,519,194.00 | 201,009,966.00 | | Other equity instruments | 50,906,662.82 | 50,956,622.11 | | Including: Preferred stock | | | | Perpetual bonds | | | | Capital reserve | 890,391,200.83 | 834,272,205.66 | | Less: Treasury shares | 164,976,000.00 | 5,628,128.21 | | Other comprehensive income | -1,611,822.41 | -1,247,674.10 | | Special reserve | | | | Surplus reserve | 100,634,780.00 | 100,634,780.00 | | General risk reserve | | | | Retained profits | 2,019,424,650.94 | 1,696,978,064.52 | | Total owners’ equity (or shareholders’ equity) attributable
to equity holders of the parent company | 3,178,288,666.18 | 2,876,975,835.98 | | Minority interests | 18,468,690.63 | 9,864,591.09 | | Total owners’ equity (or shareholders’ equity) | 3,196,757,356.81 | 2,886,840,427.07 | | Total liabilities and owners’ equity (shareholders’
equity) | 5,461,758,028.57 | 4,633,049,783.03 |
The chairman of the Company: CFO of the Company: WANG Head of Accounting HOU Juncheng Li Department: WANG Li
Consolidated Income Statement
January to September, 2022
Prepared by: Proya Cosmetics Co., Ltd.
Unit: Yuan Currency: RMB Audit Type: Unaudited
| Item | First three quarters of
2022
(Jan. to Sep.) | First three quarters of
2021
(Jan. to Sep.) | | I. Total operating income | 3,962,074,031.96 | 3,012,251,856.14 | | Including: Operating revenue | 3,962,074,031.96 | 3,012,251,856.14 | | Interest income | | | | Premiums earned | | | | Fee and commission income | | | | II. Total operating costs | 3,246,045,594.62 | 2,570,351,426.19 | | Including: Operating costs | 1,211,286,056.12 | 1,066,572,027.42 | | Interest expenses | | | | Fee and commission expenses | | | | Surrenders | | | | Claims and policyholder benefits (net of
amounts recoverable from reinsurers) | | | | Charges in insurance contract reserves
(net of reinsurers’ share) | | | | Insurance policyholder dividends | | | | Expenses for reinsurance accepted | | | | Taxes and surcharges | 35,018,710.91 | 26,755,664.49 | | Selling expenses | 1,700,908,422.25 | 1,262,122,598.38 | | General and administrative expenses | 235,718,481.10 | 165,503,097.12 | | Research and development expenses | 95,367,183.34 | 52,455,578.02 | | Financial expenses | -32,253,259.10 | -3,057,539.24 | | Including: Interest expenses | 9,827,780.80 | 7,219,717.71 | | Interest income | 42,468,258.19 | 17,843,073.35 | | Add: Other income | 23,810,575.67 | 12,758,859.43 | | Investment income (Loss is indicated
by “-”) | -6,661,294.54 | -5,257,778.42 | | Including: Income from investments in
associates and joint ventures | -6,658,316.04 | -5,254,232.18 | | Income from derecognition of financial
assets measured at amortized cost | | | | Foreign exchange gains (Loss is indicated
by “-”) | | | | Net exposure hedging income (Loss is
indicated by “-”) | | | | Income from changes in fair value (Loss is
indicated by “-”) | | | | Impairment losses of credit (Loss is
indicated by “-”) | 2,180,709.67 | -2,144,694.51 | | Impairment losses of assets (Loss is
indicated by “-”) | -113,537,444.60 | -20,365,487.85 | | Income from disposal of assets (Loss is
indicated by “-”) | | -1,416.28 | | III. Operating profit (Loss is indicated by “-”) | 621,820,983.54 | 426,889,912.32 | | Add: Non-operating income | 612,654.73 | 144,171.60 | | Less: Non-operating expenses | 916,605.93 | 63,373.82 | | IV. Total profit (Total loss is indicated by “-”) | 621,517,032.34 | 426,970,710.10 | | Less: Income tax expenses | 117,310,409.13 | 79,816,536.07 | | V. Net profit (Net loss is indicated by “-”) | 504,206,623.21 | 347,154,174.03 | | (I) Classified by the nature of continuing operations | | | | 1. Net profit from continuing operations (Net
loss is indicated by “-”) | 504,206,623.21 | 347,154,174.03 | | 2. Net profit from discontinued operations (Net
loss is indicated by “-”) | | | | (II) Classified by ownership | | | | 1. Net profit attributable to shareholders of the | 495,315,157.18 | 364,296,789.10 | | parent company (Net loss is indicated by “-”) | | | | 2. Profit or loss attributable to minority
interests (Net loss is indicated by “-”) | 8,891,466.03 | -17,142,615.07 | | VI. Other comprehensive income, net of tax | -364,148.31 | -733,371.78 | | (I) Other comprehensive income attributable to
owners of the parent company, net of tax | -364,148.31 | -733,371.78 | | 1. Other comprehensive income that cannot be
subsequently reclassified to profit or loss | | | | (1) Changes from re-measurement of defined
benefit plans | | | | (2) Other comprehensive income that cannot be
reclassified to profit or loss under the equity
method | | | | (3) Changes in fair value of other investments
in equity instruments | | | | (4) Changes in fair value of enterprises’ own
credit risks | | | | 2. Other comprehensive income that will be
reclassified to profit or loss | -364,148.31 | -733,371.78 | | (1) Other comprehensive income that will be
reclassified to profit or loss under the equity
method | | | | (2) Changes in fair value of other debt
investments | | | | (3) Amounts of financial assets reclassified into
other comprehensive income | | | | (4) Provision for credit impairment of other
debt investments | | | | (5) Reserve for cash flow hedges | | | | (6) Translation differences of financial
statements denominated in foreign currencies | -364,148.31 | -733,371.78 | | (7) Others | | | | (II) Other comprehensive income attributable to
minority interests, net of tax | | | | VII. Total comprehensive income | 503,842,474.90 | 346,420,802.25 | | (I) Total comprehensive income attributable to
owners of the parent company | 494,951,008.87 | 363,563,417.32 | | (II) Total comprehensive income attributable to
minority interests | 8,891,466.03 | -17,142,615.07 | | VIII. Earnings per share | | | | (I) Basic earnings per share (RMB/share) | 1.76 | 1.82 | | (II) Diluted earnings per share (RMB/share) | 1.74 | 1.81 |
In case of business combination under common control, net profit realized by the combined before the
combination in the current period was RMB0.00; net profit realized by the combined in the previous period was RMB0.00.
The chairman of the Head of Accounting
CFO of the Company: WANG Li
Company: HOU Juncheng Department: WANG Li
Consolidated Cash Flow Statement
January to September 2022
Prepared by: Proya Cosmetics Co., Ltd.
Unit: Yuan Currency: RMB Audit Type: Unaudited
| Item | First three quarters of
2022
(Jan. to Sep.) | First three quarters of
2021
(Jan. to Sep.) | | I. Cash flows from operating activities: | | | | Cash receipts from the sale of goods and the rendering of
services | 4,420,753,595.68 | 3,372,200,521.00 | | Net increase in customer deposits and deposits from
banks and other financial institutions | | | | Net increase in loans from the central bank | | | | Net increase in taking from other financial institutions | | | | Cash payments for claims and policyholders’ benefits
under direct insurance contracts | | | | Net cash receipts from reinsurance business | | | | Net cash receipts from policyholders’ deposits and
investment contract liabilities | | | | Cash receipts from interest, fees and commissions | | | | Net increase in taking from banks and other financial
institutions | | | | Net increase in financial assets sold under repurchase
arrangements | | | | Net cash received from securities trading agency | | | | Receipts of tax refunds | 5,217,273.91 | 18,501,241.84 | | Other cash receipts relating to operating activities | 94,308,291.64 | 59,335,619.38 | | Sub-total of cash inflows from operating activities | 4,520,279,161.23 | 3,450,037,382.22 | | Cash payments for goods purchased and services
received | 1,333,409,994.35 | 1,046,478,917.19 | | Net increase in loans and advances to customers | | | | Net increase in balance with the central bank and due
from banks and other financial institution | | | | Cash payments for claims and policyholders’ benefits
under direct insurance contracts | | | | Net increase in placements with banks and other financial
institutions | | | | Cash payments for interest, fees and commissions | | | | Cash payments for insurance policyholder dividends | | | | Cash payments to and on behalf of employees | 381,128,046.79 | 329,997,403.51 | | Payments of various types of taxes | 398,116,900.07 | 336,370,801.47 | | Other cash payments relating to operating activities | 1,635,750,886.35 | 1,246,701,763.29 | | Sub-total of cash outflows from operating activities | 3,748,405,827.56 | 2,959,548,885.46 | | Net cash flow from operating activities | 771,873,333.67 | 490,488,496.76 | | II. Cash flows from investing activities: | | | | Cash receipts from disposals and recovery of investments | | | | Cash receipts from investment income | | | | Net cash receipts from disposals of fixed assets,
intangible assets and other long-term assets | | 1,000.00 | | Net cash receipts from disposals of subsidiaries and other
business entities | | | | Other cash receipts relating to investing activities | | | | Sub-total of cash inflows from investing activities | | 1,000.00 | | Cash payments to acquire or construct fixed assets,
intangible assets and other long-term assets | 98,040,024.48 | 163,266,984.07 | | Cash payments to acquire investments | 104,185,427.27 | 34,206,800.00 | | Net increase in pledged loans receivables | | | | Net cash payments for acquisitions of subsidiaries and
other business units | | | | Other cash payments relating to investing activities | | 61,087,857.19 | | Sub-total of cash outflows from investing activities | 202,225,451.75 | 258,561,641.26 | | Net cash flow from investing activities | -202,225,451.75 | -258,560,641.26 | | III. Cash flows from financing activities: | | | | Cash receipts from capital contributions | 165,676,000.00 | 450,000.00 | | Including: cash receipts from capital contributions from | 700,000.00 | 450,000.00 | | minority owners of subsidiaries | | | | Cash receipts from borrowings | 200,000,000.00 | 200,000,000.00 | | Other cash receipts relating to financing activities | | | | Sub-total of cash inflows from financing activities | 365,676,000.00 | 200,450,000.00 | | Cash repayments of borrowings | 200,000,000.00 | 299,000,000.00 | | Cash payments for distribution of dividends or profits or
settlement of interest expenses | 178,569,824.95 | 151,549,422.10 | | Including: payments for distribution of dividends or
profits to minority owners of subsidiaries | | | | Other cash payments relating to financing activities | 45,800,000.00 | 1,647,883.50 | | Sub-total of cash outflows from financing activities | 424,369,824.95 | 452,197,305.60 | | Net cash flow from financing activities | -58,693,824.95 | -251,747,305.60 | | IV. Impact of foreign exchange rate changes on cash and
cash equivalents | -364,148.31 | -733,371.78 | | V. Net increase in cash and cash equivalents | 510,589,908.66 | -20,552,821.88 | | Add: Opening balance of cash and cash equivalents | 2,378,334,768.09 | 1,401,850,754.88 | | VI. Closing balance of cash and cash equivalents | 2,888,924,676.75 | 1,381,297,933.00 |
（未完）
|
|
